Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Vanda Pharmaceuticals (VNDA) Change in Accured Expenses (2016 - 2025)

Vanda Pharmaceuticals' Change in Accured Expenses history spans 16 years, with the latest figure at $9.1 million for Q4 2025.

  • On a quarterly basis, Change in Accured Expenses rose 526.75% to $9.1 million in Q4 2025 year-over-year; TTM through Dec 2025 was $15.8 million, a 826.23% increase, with the full-year FY2025 number at $15.8 million, up 826.23% from a year prior.
  • Change in Accured Expenses hit $9.1 million in Q4 2025 for Vanda Pharmaceuticals, up from -$10.2 million in the prior quarter.
  • Over the last five years, Change in Accured Expenses for VNDA hit a ceiling of $13.4 million in Q1 2022 and a floor of -$10.8 million in Q1 2023.
  • Historically, Change in Accured Expenses has averaged $1.1 million across 5 years, with a median of $735500.0 in 2022.
  • Biggest five-year swings in Change in Accured Expenses: surged 4878.57% in 2022 and later tumbled 2079.74% in 2025.
  • Tracing VNDA's Change in Accured Expenses over 5 years: stood at $2.2 million in 2021, then tumbled by 250.32% to -$3.3 million in 2022, then surged by 201.65% to $3.3 million in 2023, then plummeted by 163.85% to -$2.1 million in 2024, then skyrocketed by 526.75% to $9.1 million in 2025.
  • Business Quant data shows Change in Accured Expenses for VNDA at $9.1 million in Q4 2025, -$10.2 million in Q3 2025, and $11.3 million in Q2 2025.